Expression of DNA Methyltransferase (DNMT) 1, 3a and 3b proteins in human hepatocellular carcinoma

Yonago Acta Medica

Volumn 53, Issue 1, 2010, Pages 1-7

  Miyake, Takanori ^a   Endo, Kanenori ^a   Honjo, Soichiro ^a   Hirooka, Yasuaki ^a   Ikeguchi, Masahide ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

DNA methyltransferase; Hepatocellular carcinoma; Immunohistochemistry; Prognosis

Indexed keywords

DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3A; DNA METHYLTRANSFERASE 3B;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; LIVER METASTASIS; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PORTAL VEIN; PROGNOSIS; PROTEIN EXPRESSION; SURVIVAL RATE; TUMOR DIFFERENTIATION;

EID: 77949859374     PISSN: 05135710     EISSN: 13468049     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Arai M, Yokosuka O, Hirasawa Y, Fukai K, et al. Sequential gene expression changes in cancer cell lines after treatment with the demethylation agent 5-aza-2′-deoxycytidine. Cancer 2006;106:2514-2525.
2. Choi MS, Shim YH, Hwa JY, Lee SK, et al. Expression of DNA methyltransferases in multistep hepatocarcinogenesis. Hum Pathol 2003;34:11-17.
3. Ding WG, Fang JY, Chen XY, Peng YS. The expression and clinical significance of DNA methyltransferase proteins in human gastric cancer. Dig Dis Sci 2008;53:2083-2089.
4. Girault I, Tozlu S, Lidereau R, Bièche I. Expression analysis of DNA methyltransferases 1, 3A, and 3B in sporadic breast carcinomas. Clin Cancer Res 2003;9:4415-4422.
5. Hattori N, Abe T, Hattori N, Suzuki M, et al. Preference of DNA methyltransferases for CpG islands in mouse embryonic stem cells. Genome Res 2004;14:1733-1740.
6. Juttermann R, Li E, Jaenische R. Toxicity of 5-aza-2′-deoxycytidine to mammalian cells is mediated primarily by covalent trapping of DNA methyltransferase rather than DNA demethylation. Proc Natl Acad Sci USA 1994;91:11797-11801.
7. Kanai Y, Ushijima S, Hui AM, Ochiai A, et al. The Ecadherin gene is silenced by CpG methylation in human hepatocellular carcinomas. Int J Cancer 1997;71:355-359.
8. Kim GD, Ni J, Kelesoglu N, Roberts RJ, et al. Cooperation and communication between the human maintenance and de novo DNA (cytosine-5) methyltransferases. EMBO J 2002;21:4183-4195.
9. Kozyraki R, Scoazec JY, Flejou JF, D'Errico A, et al. Expression of cadherins and alpha-catenin in primary epithelial tumors of the liver. Gastroenterology 1996;110:1137-1149.
10. Lee S, Lee HJ, Kim JH, Lee HS, et al. Aberrant CpG island hypermethylation along multistep hepatocarcinogenesis. Am J Pathol 2003;163:1371-1378.
11. Lin RK, Hsu HS, Chang JW, Chen CY, et al. Alteration of DNA methyltransferases contributes to 5'CpG methylation and poor prognosis in lung cancer. Lung Cancer 2007;55:205-213.
12. Łuczak MW, Jagodzinski PP. The role of DNA methylation in cancer development. Folia Histochem Cytobiol 2006;44:143-154.
13. Mulero-Navarro S, Esteller M. Epigenetic biomarkers for human cancer: The time is now. Crit Rev Oncol Hematol 2008;68:1-11.
14. Nosho K, Shima K, Irahara N, Kure S, et al. DNMT3B expression might contribute to CpG island methylator phenotype in colorectal cancer. Clin Cancer Res 2009;15:3663-3671.
15. Oh BK, Kim H, Park HJ, Shim YH, et al. DNA methyl-transferase expression and DNA methylation in human hepatocellular carcinoma and their clinicopathological correlation. Int J Mol Med 2007;20:65-73.
16. Rahnama F, Thompson B, Steiner M, Shafiei F, et al. Epigenetic regulation of E-cadherin controls endometrial receptivity. Endocrinology 2009;150:1466-1472.
17. Rhee I, Bachman KE, Park BH, Jair KW, et al. DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nature 2002;416:552-556.
18. Roncalli M, Bianchi P, Bruni B, Laghi L, et al. Methylation framework of cell cycle gene inhibitors in cirrhosis and associated hepatocellular carcinoma. Hepatology 2002;36:427-432.
19. Saito Y, Kanai Y, Nakagawa T, Sakamoto M, et al. Increased protein expression of DNA methyltransferase (DNMT) 1 is significantly correlated with the malignant potential and poor prognosis of human hepatocellular carcinomas. Int J Cancer 2003;105:527-532.
20. Saito Y, Kanai Y, Sakamoto M, Saito H, et al. Expression of mRNA for DNA methyltransferases and methyl-CpG-binding proteins and DNA methylation status on CpG islands and pericentromeric satellite regions during human hepatocarcinogenesis. Hepatology 2001;33: 561-568.
21. Yang B, Guo M, Herman JG, Clark DP. Aberrant promoter methylation profiles of tumor suppressor genes in hepatocellular carcinoma. Am J Pathol 2003;163:1101-1107.
22. Yang X, Phillips DL, Ferguson AT, Nelson W, et al. Synergistic activation of functional estrogen receptor (ER)-alpha by DNA methyltransferase and histone deacetylase inhibition in human ER-alpha-negative breast cancer cells. Cancer Res 2001;61:7025-7029.